1-62238462-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_181712.5(KANK4):c.2884-81T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.352 in 1,179,684 control chromosomes in the GnomAD database, including 75,366 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.36 ( 9851 hom., cov: 31)
Exomes 𝑓: 0.35 ( 65515 hom. )
Consequence
KANK4
NM_181712.5 intron
NM_181712.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.21
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 1-62238462-A-G is Benign according to our data. Variant chr1-62238462-A-G is described in ClinVar as [Benign]. Clinvar id is 1249680.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.37 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KANK4 | NM_181712.5 | c.2884-81T>C | intron_variant | ENST00000371153.9 | NP_859063.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KANK4 | ENST00000371153.9 | c.2884-81T>C | intron_variant | 1 | NM_181712.5 | ENSP00000360195.4 | ||||
KANK4 | ENST00000354381.3 | c.1000-81T>C | intron_variant | 2 | ENSP00000346352.3 | |||||
KANK4 | ENST00000371150.5 | c.952-81T>C | intron_variant | 2 | ENSP00000360192.1 | |||||
KANK4 | ENST00000317477.8 | c.298-81T>C | intron_variant | 2 | ENSP00000321161.4 |
Frequencies
GnomAD3 genomes AF: 0.356 AC: 54103AN: 151776Hom.: 9836 Cov.: 31
GnomAD3 genomes
AF:
AC:
54103
AN:
151776
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.352 AC: 361301AN: 1027790Hom.: 65515 AF XY: 0.349 AC XY: 183124AN XY: 524970
GnomAD4 exome
AF:
AC:
361301
AN:
1027790
Hom.:
AF XY:
AC XY:
183124
AN XY:
524970
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.357 AC: 54156AN: 151894Hom.: 9851 Cov.: 31 AF XY: 0.356 AC XY: 26434AN XY: 74240
GnomAD4 genome
AF:
AC:
54156
AN:
151894
Hom.:
Cov.:
31
AF XY:
AC XY:
26434
AN XY:
74240
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
780
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 12, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at